Medication-related osteonecrosis of the jaw incidence in patients exposed concomitantly to bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors: is it generalizable to all solid tumors?

Growth Factor ◽

Bone Resorption ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Osteonecrosis Of The Jaw ◽

Vascular Endothelial ◽

Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors

Supportive Care in Cancer ◽

10.1007/s00520-017-3903-5 ◽

2017 ◽

Vol 26 (3) ◽

pp. 869-878 ◽

Cited By ~ 11

Author(s):

T. van Cann ◽

T. Loyson ◽

A. Verbiest ◽

P. M. Clement ◽

O. Bechter ◽

...

Keyword(s):

Growth Factor ◽

Bone Resorption ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Osteonecrosis Of The Jaw ◽

Vascular Endothelial ◽

Risks of Proteinuria Associated with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis

PLoS ONE ◽

10.1371/journal.pone.0090135 ◽

2014 ◽

Vol 9 (3) ◽

pp. e90135 ◽

Cited By ~ 31

Author(s):

Ze-Feng Zhang ◽

Tao Wang ◽

Li-Hua Liu ◽

Hui-Qin Guo

Keyword(s):

Systematic Review ◽

Growth Factor ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Hepatotoxicity of vascular endothelial growth factor receptor tyrosine kinase inhibitors: clinical practice and evidence

Drugs & Therapy Perspectives ◽

10.1007/s40267-017-0416-8 ◽

2017 ◽

Vol 33 (8) ◽

pp. 395-402

Author(s):

Bulent Cetin ◽

Irem Bilgetekin ◽

Mustafa Cengiz ◽

Ahmet Ozet

Keyword(s):

Clinical Practice ◽

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2014.12.008 ◽

2015 ◽

Vol 94 (2) ◽

pp. 228-237 ◽

Cited By ~ 55

Author(s):

Pooja Ghatalia ◽

Charity J. Morgan ◽

Youjin Je ◽

Paul L. Nguyen ◽

Quoc-Dien Trinh ◽

...

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation¶

Journal of Medicinal Chemistry ◽

10.1021/jm701097z ◽

2008 ◽

Vol 51 (6) ◽

pp. 1649-1667 ◽

Cited By ~ 43

Author(s):

Jean-Christophe Harmange ◽

Matthew M. Weiss ◽

Julie Germain ◽

Anthony J. Polverino ◽

George Borg ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Design Synthesis ◽

PotentN-(1,3-Thiazol-2-yl)pyridin-2-amine Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors with Excellent Pharmacokinetics and Low Affinity for the hERG Ion Channel

Journal of Medicinal Chemistry ◽

10.1021/jm049697f ◽

2004 ◽

Vol 47 (25) ◽

pp. 6363-6372 ◽

Cited By ~ 40

Author(s):

Mark T. Bilodeau ◽

Adrienne E. Balitza ◽

Timothy J. Koester ◽

Peter J. Manley ◽

Leonard D. Rodman ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Ion Channel ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Prognostic tissue biomarker exploration for patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors

Tumor Biology ◽

10.1007/s13277-015-4339-5 ◽

2015 ◽

Vol 37 (4) ◽

pp. 4919-4927 ◽

Cited By ~ 4

Author(s):

Inkeun Park ◽

Yong Mee Cho ◽

Jae-Lyun Lee ◽

Jin-Hee Ahn ◽

Dae-Ho Lee

Keyword(s):

Renal Cell Carcinoma ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Tissue Biomarker ◽

Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584

Seminars in Oncology ◽

10.1016/s0093-7754(03)00123-4 ◽

2003 ◽

Vol 30 (3 Suppl 6) ◽

pp. 32-38 ◽

Cited By ~ 32

Author(s):

Anne L. Thomas ◽

Bruno Morgan ◽

Joachim Drevs ◽

Clemens Unger ◽

Bertram Wiedenmann ◽

...

Keyword(s):

Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitors ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e13502 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e13502-e13502

Author(s):

Pooja Ghatalia ◽

Charity Morgan ◽

Toni K. Choueiri ◽

Guru Sonpavde

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Growth Factor ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Is there truly an increase in risk of cardiovascular and hematological adverse events with vascular endothelial growth factor receptor tyrosine kinase inhibitors?

Expert Opinion on Drug Safety ◽

10.1080/14740338.2020.1691167 ◽

2019 ◽

Vol 19 (2) ◽

pp. 223-228

Author(s):

Luis Furuya-Kanamori ◽

Suhail Ar Doi ◽

Adedayo Onitilo ◽

Saghir Akhtar

Keyword(s):

Growth Factor ◽

Adverse Events ◽

Kinase Inhibitors ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Receptor Tyrosine Kinase Inhibitors ◽

Increase In Risk